1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Needle-Free Drug Injection Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Needle-Free Drug Injection Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Jet-Based Needle-Free Injectors
1.4.3 Spring-Based Needle-Free Injectors
1.4.4 Laser-Powered Needle-Free Injectors
1.4.5 Vibration-Based Needle-Free Injectors
1.5 Market by Application
1.5.1 Global Needle-Free Drug Injection Systems Market Share by Application: 2021-2026
1.5.2 Hospitals and Clinics
1.5.3 Homecare Settings
1.5.4 Research Laboratories
1.5.5 Pharmaceutical and Biotechnology companies
1.5.6 Other End Users
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Needle-Free Drug Injection Systems Market
1.8.1 Global Needle-Free Drug Injection Systems Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Needle-Free Drug Injection Systems Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Needle-Free Drug Injection Systems Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Needle-Free Drug Injection Systems Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Needle-Free Drug Injection Systems Sales Volume Market Share by Region (2015-2020)
3.2 Global Needle-Free Drug Injection Systems Sales Revenue Market Share by Region (2015-2020)
3.3 North America Needle-Free Drug Injection Systems Sales Volume
3.3.1 North America Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.3.2 North America Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Needle-Free Drug Injection Systems Sales Volume
3.4.1 East Asia Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.5.1 Europe Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.6.1 South Asia Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.7.1 Southeast Asia Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.8.1 Middle East Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.9.1 Africa Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.10.1 Oceania Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.11.1 South America Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.11.2 South America Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Needle-Free Drug Injection Systems Sales Volume (2015-2020)
3.12.1 Rest of the World Needle-Free Drug Injection Systems Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Needle-Free Drug Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Needle-Free Drug Injection Systems Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Needle-Free Drug Injection Systems Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Needle-Free Drug Injection Systems Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Needle-Free Drug Injection Systems Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Needle-Free Drug Injection Systems Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Needle-Free Drug Injection Systems Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Needle-Free Drug Injection Systems Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Needle-Free Drug Injection Systems Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Needle-Free Drug Injection Systems Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Needle-Free Drug Injection Systems Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Needle-Free Drug Injection Systems Sales Volume Market Share by Type (2015-2020)
14.2 Global Needle-Free Drug Injection Systems Sales Revenue Market Share by Type (2015-2020)
14.3 Global Needle-Free Drug Injection Systems Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Needle-Free Drug Injection Systems Consumption Volume by Application (2015-2020)
15.2 Global Needle-Free Drug Injection Systems Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Needle-Free Drug Injection Systems Business
16.1 Antares Pharma, Inc. (US)
16.1.1 Antares Pharma, Inc. (US) Company Profile
16.1.2 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Specification
16.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Valeritas, Inc. (US)
16.2.1 Valeritas, Inc. (US) Company Profile
16.2.2 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Specification
16.2.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Bioject Medical Technologies Inc. (U.S)
16.3.1 Bioject Medical Technologies Inc. (U.S) Company Profile
16.3.2 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Specification
16.3.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Endo International plc (US)
16.4.1 Endo International plc (US) Company Profile
16.4.2 Endo International plc (US) Needle-Free Drug Injection Systems Product Specification
16.4.3 Endo International plc (US) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 National Medical Products Inc. (US)
16.5.1 National Medical Products Inc. (US) Company Profile
16.5.2 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Specification
16.5.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 PharmaJet (U.S)
16.6.1 PharmaJet (U.S) Company Profile
16.6.2 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Specification
16.6.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 PenJet Corporation (U.S)
16.7.1 PenJet Corporation (U.S) Company Profile
16.7.2 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Specification
16.7.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 INJEX Pharma AG (Germany)
16.8.1 INJEX Pharma AG (Germany) Company Profile
16.8.2 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Specification
16.8.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Medical International Technology, Inc. (U.S)
16.9.1 Medical International Technology, Inc. (U.S) Company Profile
16.9.2 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Specification
16.9.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 European Pharma Group (Netherland)
16.10.1 European Pharma Group (Netherland) Company Profile
16.10.2 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Specification
16.10.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Crossject SA (France)
16.11.1 Crossject SA (France) Company Profile
16.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Product Specification
16.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Needle-Free Drug Injection Systems Manufacturing Cost Analysis
17.1 Needle-Free Drug Injection Systems Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Needle-Free Drug Injection Systems
17.4 Needle-Free Drug Injection Systems Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Needle-Free Drug Injection Systems Distributors List
18.3 Needle-Free Drug Injection Systems Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Needle-Free Drug Injection Systems (2021-2026)
20.2 Global Forecasted Revenue of Needle-Free Drug Injection Systems (2021-2026)
20.3 Global Forecasted Price of Needle-Free Drug Injection Systems (2015-2026)
20.4 Global Forecasted Production of Needle-Free Drug Injection Systems by Region (2021-2026)
20.4.1 North America Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.3 Europe Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.7 Africa Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.9 South America Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Needle-Free Drug Injection Systems Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Needle-Free Drug Injection Systems by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.2 East Asia Market Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.3 Europe Market Forecasted Consumption of Needle-Free Drug Injection Systems by Countriy
21.4 South Asia Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.5 Southeast Asia Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.6 Middle East Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.7 Africa Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.8 Oceania Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.9 South America Forecasted Consumption of Needle-Free Drug Injection Systems by Country
21.10 Rest of the world Forecasted Consumption of Needle-Free Drug Injection Systems by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer